Abstract: There is increasing impetus to use pharmaceutical interventions, ie, ranibizumab or bevacizumab, for the treatment of particular macular diseases. This paper describes the evidence and decision-making of the National List of Essential Medicines Committee that recently announced the inclusi

Doctors were told last month that we should stop doing so many screenings for prostate cancer with the prostate-specific antigen test. We learned that sigmoidoscopy is a cheaper, easier and effective alternative to colonoscopy for colon cancer screening. And a study I led turned up strong evidence t

Antimicrobial resistance (AMR) will continue to significantly impact healthcare and public health around the world. Given the complexity of AMR and the multi-dimensional nature of its aetiology and impact, a multi-sectoral and inter-disciplinary approach is required to mitigate its impact. “One Health” is an approach to designing and implementi

HPV vaccination policy in Thailand had been largely driven by the unaffordable prices of vaccine products. Although domestic HTA in formation, including health economic data of intervention, had been available, such evidence play a limited role in HPV vaccination policy formulation. Existing cost-effectiveness studies have resulted in efforts to im

Physical Activity at Work (PAW) program is a collaborative research between Health Intervention and Technology Assessment Program (HITAP), Department of Medical Services (DMS), Saw Swee Hock School of Public Health (SSHSPH) and Hitotsubashi University. As sedentary behaviours (SBs) are known to be associated with higher risks of all-cause mortality

Summary Background Sedentary behaviour increases the risks of non-communicable diseases. The objective of this trial was to evaluate the effect of the Physical Activity at Work multicomponent intervention to reduce sedentary behaviour in Thai office workers. Methods Offices under the Ministr

Abstract Background: High levels of sedentary behaviour (SB) are associated with non-communicable diseases. In 2016, the estimated total healthcare expenditure from physical activity (PA) in Thailand added up to $190 million in international dollars. The challenge to reduce SB and increase PA amo

Australia developed the Life-Saving Drugs Program (LSDP) in 1995 to complement the Pharmaceutical Benefits Scheme (PBS), expanding access to high-cost drugs for rare diseases (DRD). This program, funded and administered by the Department of Health and Aged Care, permitted sponsors (often pharmaceuti